Dr. Erik Suh has become SUBOXONE Certified to prescribe, and help patients come off of opioid dependence.
Under DATA 2000, qualified physicians may obtain a waiver allowing them to prescribe and/or dispense approved Schedule III-V medications for the treatment of opioid dependence. Previously, this type of treatment was available only in federally approved Opioid Treatment Programs, namely, methadone clinics.
For the first time in more than 30 years, qualifying physicians have the legal right to use approved opioid medications (eg, SUBOXONE) to treat opioid dependence in the privacy of an office-based setting.
SUBOXONE is the first opioid medication approved for the treatment of opioid dependence in an office-based setting. SUBOXONE also can be dispensed for take-home use, just as any other medicine for other medical conditions.
The primary active ingredient in SUBOXONE is buprenorphine.
Because buprenorphine is a partial opioid agonist, its opioid effects are limited compared with those produced by full opioid agonists, such as oxycodone or heroin. SUBOXONE also contains naloxone, an opioid antagonist.
The naloxone in SUBOXONE is there to discourage people from dissolving the tablet and injecting it. When SUBOXONE is placed under the tongue, as directed, very little naloxone reaches the bloodstream, so what the patient feels are the effects of the buprenorphine. However, if naloxone is injected, it can cause a person dependent on a full opioid agonist to quickly go into withdrawal.
SUBOXONE at the appropriate dose may be used to:
- Reduce illicit opioid use
- Help patients stay in treatment by:
- Suppressing symptoms of opioid withdrawal
- Decreasing cravings for opioids
Call the office for more information on suboxone treatment for opioid dependence.